{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:18:23Z","timestamp":1790572703355,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mitochondrial dysfunction plays a key role in doxorubicin-induced cardiotoxicity (DIC). In this proof-of-principle study, we investigated whether PET mapping of cardiac membrane potential, an indicator of mitochondrial function, could detect an acute cardiotoxic effect of doxorubicin (DOX) in a large animal model. Eight Yucatan pigs were imaged dynamically with [<jats:sup>18<\/jats:sup>F](4-Fluorophenyl)triphenylphosphonium ([<jats:sup>18<\/jats:sup>F]FTPP<jats:sup>+<\/jats:sup>) PET\/CT. Our experimental protocol included a control saline infusion into the left anterior descending coronary artery (LAD) followed by a DOX test infusion of either 1\u00a0mg\/kg or 2\u00a0mg\/kg during PET. We measured the change in total cardiac membrane potential (\u0394\u03a8<jats:sub>T<\/jats:sub>), a proxy for the mitochondrial membrane potential, \u0394\u03a8<jats:sub>m<\/jats:sub>, after the saline and DOX infusions. We observed a partial depolarization of the mitochondria following the DOX infusions, which occurred only in myocardial areas distal to the intracoronary catheter, thereby demonstrating a direct association between the exposure of the mitochondria to DOX and a change in \u0394\u03a8<jats:sub>T<\/jats:sub>. Furthermore, doubling the DOX dose caused a more severe depolarization of myocardium in the LAD territory distal to the infusion catheter. In conclusion, [<jats:sup>18<\/jats:sup>F]FTPP<jats:sup>+<\/jats:sup> PET-based \u0394\u03a8<jats:sub>T<\/jats:sub> mapping can measure partial depolarization of myocardial mitochondria following intracoronary DOX infusion in a large animal model.<\/jats:p>","DOI":"10.1038\/s41598-022-10004-6","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:03:13Z","timestamp":1649768593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study"],"prefix":"10.1038","volume":"12","author":[{"given":"Felicitas J.","family":"Detmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel M.","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hyun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Dhaynaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Luis","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J.","family":"Guehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Brugarolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Shoup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"El Fakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Petibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"10004_CR1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","volume":"107","author":"H Sawaya","year":"2011","unstructured":"Sawaya, H. et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am. J. Cardiol. 107, 1375\u20131380 (2011).","journal-title":"Am. J. Cardiol."},{"key":"10004_CR2","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/ejhf.1330","volume":"20","author":"J \u010celutkien\u0117","year":"2018","unstructured":"\u010celutkien\u0117, J. et al. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the heart failure association of the European society of cardiology. Eur. J. Heart Fail. 20, 1615\u20131633 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"10004_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1080\/14779072.2016.1239528","volume":"14","author":"D Cardinale","year":"2016","unstructured":"Cardinale, D. & Cipolla, C. M. Chemotherapy-induced cardiotoxicity: importance of early detection. Exp. Rev. Cardiovasc. Ther. 14, 1297\u20131299 (2016).","journal-title":"Exp. Rev. Cardiovasc. Ther."},{"key":"10004_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000455823","volume":"62","author":"P Menna","year":"2017","unstructured":"Menna, P. & Salvatorelli, E. Primary prevention strategies for anthracycline cardiotoxicity: a brief overview. Chemotherapy 62, 159\u2013168 (2017).","journal-title":"Chemotherapy"},{"key":"10004_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/mol.119.115725","volume":"96","author":"N Wenningmann","year":"2019","unstructured":"Wenningmann, N., Knapp, M., Ande, A., Vaidya, T. R. & Ait-Oudhia, S. Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring. Mol. Pharmacol. 96, 219 (2019).","journal-title":"Mol. Pharmacol."},{"key":"10004_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40360-021-00518-6","volume":"22","author":"B Sacks","year":"2021","unstructured":"Sacks, B. et al. Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment. BMC Pharmacol. Toxicol. 22, 49 (2021).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10004_CR7","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2967\/jnumed.119.226787","volume":"60","author":"SP McCluskey","year":"2019","unstructured":"McCluskey, S. P. et al. Imaging of chemotherapy-induced acute cardiotoxicity with 18 F-labeled lipophilic cations. J. Nucl. Med. 60, 1750\u20131756 (2019).","journal-title":"J. Nucl. Med."},{"key":"10004_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11886-020-01315-z","volume":"22","author":"J Sivapackiam","year":"2020","unstructured":"Sivapackiam, J., Sharma, M., Schindler, T. H. & Sharma, V. PET radiopharmaceuticals for imaging chemotherapy-induced cardiotoxicity. Curr. Cardiol. Rep. 22, 62 (2020).","journal-title":"Curr. Cardiol. Rep."},{"key":"10004_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","volume":"51","author":"JN Peoples","year":"2019","unstructured":"Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T. & Kwong, J. Q. Mitochondrial dysfunction and oxidative stress in heart disease. Exp. Mol. Med. 51, 1\u201313 (2019).","journal-title":"Exp. Mol. Med."},{"key":"10004_CR10","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/gerona\/glu056","volume":"69","author":"AG Richardson","year":"2014","unstructured":"Richardson, A. G. & Schadt, E. E. The role of macromolecular damage in aging and age-related disease. J. Gerontol. A. Biol. Sci. Med. Sci. 69, S28\u2013S32 (2014).","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"10004_CR11","doi-asserted-by":"publisher","first-page":"E5537","DOI":"10.1073\/pnas.1414665111","volume":"111","author":"R Dhingra","year":"2014","unstructured":"Dhingra, R. et al. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling. Proc. Natl. Acad. Sci. 111, E5537\u2013E5544 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10004_CR12","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.bbamcr.2011.03.002","volume":"1813","author":"AV Kuznetsov","year":"2011","unstructured":"Kuznetsov, A. V., Margreiter, R., Amberger, A., Saks, V. & Grimm, M. Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim. Biophys. Acta BBA Mol. Cell Res. 1813, 1144\u20131152 (2011).","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"10004_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.taap.2010.01.006","volume":"244","author":"D Montaigne","year":"2010","unstructured":"Montaigne, D. et al. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart. Toxicol. Appl. Pharmacol. 244, 300\u2013307 (2010).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10004_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF01868720","volume":"49","author":"N Kamo","year":"1979","unstructured":"Kamo, N., Muratsugu, M., Hongoh, R. & Kobatake, Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 49, 105\u2013121 (1979).","journal-title":"J. Membr. Biol."},{"key":"10004_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11307-010-0349-2","volume":"13","author":"TM Shoup","year":"2011","unstructured":"Shoup, T. M. et al. Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium Ion. A potential myocardial blood flow agent for PET. Mol. Imag. Biol. 13, 511\u2013517 (2011).","journal-title":"Mol. Imag. Biol."},{"key":"10004_CR16","doi-asserted-by":"publisher","first-page":"e0190968","DOI":"10.1371\/journal.pone.0190968","volume":"13","author":"NM Alpert","year":"2018","unstructured":"Alpert, N. M. et al. Quantitative in vivo mapping of myocardial mitochondrial membrane potential. PLoS ONE 13, e0190968 (2018).","journal-title":"PLoS ONE"},{"key":"10004_CR17","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00259-007-0500-8","volume":"34","author":"I Madar","year":"2007","unstructured":"Madar, I. et al. Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation. Eur. J. Nucl. Med. Mol. Imag. 34, 2057\u20132065 (2007).","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10004_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fphys.2020.00491","volume":"11","author":"NM Alpert","year":"2020","unstructured":"Alpert, N. M. et al. In-vivo imaging of mitochondrial depolarization of myocardium with positron emission tomography and a proton gradient uncoupler. Front. Physiol. 11, 491 (2020).","journal-title":"Front. Physiol."},{"key":"10004_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00259-020-04878-9","volume":"48","author":"M Pelletier-Galarneau","year":"2021","unstructured":"Pelletier-Galarneau, M. et al. In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study. Eur. J. Nucl. Med. Mol. Imag. 48, 414\u2013420 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10004_CR20","unstructured":"National Research Council. Guide for the care and use of laboratory animals. (National Academies Press, 2011)."},{"key":"10004_CR21","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 20. PLOS Biol. 18, e3000411 (2020).","journal-title":"PLOS Biol."},{"key":"10004_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jcbfm.1993.6","volume":"13","author":"RE Carson","year":"1993","unstructured":"Carson, R. E. et al. Comparison of bolus and infusion methods for receptor quantitation: application to [18 F]cyclofoxy and positron emission tomography. J. Cereb. Blood Flow Metab. 13, 24\u201342 (1993).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10004_CR23","unstructured":"Leary, S. L. & American Veterinary Medical Association. AVMA guidelines for the euthanasia of animals: 2013 edition. (2013)."},{"key":"10004_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11886-021-01500-8","volume":"23","author":"M Pelletier-Galarneau","year":"2021","unstructured":"Pelletier-Galarneau, M. et al. Quantification of myocardial mitochondrial membrane potential using PET. Curr. Cardiol. Rep. 23, 70 (2021).","journal-title":"Curr. Cardiol. Rep."},{"key":"10004_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","volume":"24","author":"E Barth","year":"1992","unstructured":"Barth, E., St\u00e4mmler, G., Speiser, B. & Schaper, J. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J. Mol. Cell. Cardiol. 24, 669\u2013681 (1992).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10004_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jcct.2015.07.001","volume":"9","author":"TA Treibel","year":"2015","unstructured":"Treibel, T. A. et al. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J. Cardiovasc. Comput. Tomogr. 9, 585\u2013592 (2015).","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"10004_CR27","unstructured":"Johnson H.J., McCormick M.M., Ibanez, I. The ITK software guide: design and functionality; updated for ITK version 4.7, 4th. Edition. Kitware Inc. (2015)."},{"key":"10004_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"D Cerqueira Manuel","year":"2002","unstructured":"Cerqueira Manuel, D. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation 105, 539\u2013542 (2002).","journal-title":"Circulation"},{"key":"10004_CR29","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing Version 3.6.2. https:\/\/www.R-project.org\/ (2016)."},{"key":"10004_CR30","doi-asserted-by":"crossref","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B., & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, (2015).","DOI":"10.18637\/jss.v067.i01"},{"key":"10004_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF02288586","volume":"6","author":"FE Satterthwaite","year":"1941","unstructured":"Satterthwaite, F. E. Synthesis of variance. Psychometrika 6, 309\u2013316 (1941).","journal-title":"Psychometrika"},{"key":"10004_CR32","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan, P. et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy. J. Am. Coll. Cardiol. 63, 2751\u20132768 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10004_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","volume":"77","author":"P Thavendiranathan","year":"2021","unstructured":"Thavendiranathan, P. et al. Strain-guided management of potentially cardiotoxic cancer therapy. J. Am. Coll. Cardiol. 77, 392\u2013401 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10004_CR34","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1038\/s41598-017-02627-x","volume":"7","author":"YJ Hong","year":"2017","unstructured":"Hong, Y. J. et al. Early detection and serial monitoring of anthracycline-induced cardiotoxicity using T1-mapping cardiac magnetic resonance imaging: an animal study. Sci. Rep. 7, 2663 (2017).","journal-title":"Sci. Rep."},{"key":"10004_CR35","doi-asserted-by":"publisher","first-page":"P273","DOI":"10.1186\/1532-429X-16-S1-P273","volume":"16","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan, P., et al. Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab. J. Cardiovasc. Magn. Reson. 16, P273 (2014).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10004_CR36","first-page":"392","volume":"18","author":"C Charbonnel","year":"2017","unstructured":"Charbonnel, C. et al. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur. Heart J. Cardiovasc. Imag. 18, 392\u2013401 (2017).","journal-title":"Eur. Heart J. Cardiovasc. Imag."},{"key":"10004_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jacc.2018.11.046","volume":"73","author":"C Gal\u00e1n-Arriola","year":"2019","unstructured":"Gal\u00e1n-Arriola, C. et al. Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J. Am. Coll. Cardiol. 73, 779\u2013791 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10004_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0014-2999(01)01096-2","volume":"423","author":"G-X Wang","year":"2001","unstructured":"Wang, G.-X., Wang, Y.-X., Zhou, X.-B. & Korth, M. Effects of doxorubicinol on excitation\u2013contraction coupling in guinea pig ventricular myocytes. Eur. J. Pharmacol. 423, 99\u2013107 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"10004_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0140-6736(16)30587-6","volume":"388","author":"WD Tap","year":"2016","unstructured":"Tap, W. D. et al. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Lancet 388, 488\u2013497 (2016).","journal-title":"Lancet"},{"key":"10004_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2165\/00003088-200746120-00005","volume":"46","author":"M Joerger","year":"2007","unstructured":"Joerger, M. et al. Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group. Clin. Pharmacokinet. 46, 1051\u20131068 (2007).","journal-title":"Clin. Pharmacokinet."},{"key":"10004_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0005-2728(87)90236-2","volume":"892","author":"K Nicolay","year":"1987","unstructured":"Nicolay, K. & de Kruijff, B. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Biochim. Biophys. Acta BBA Bioenerg. 892, 320\u2013330 (1987).","journal-title":"Biochim. Biophys. Acta BBA Bioenerg."},{"key":"10004_CR42","doi-asserted-by":"publisher","first-page":"e12733","DOI":"10.1371\/journal.pone.0012733","volume":"5","author":"AV Pointon","year":"2010","unstructured":"Pointon, A. V. et al. Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation. PLoS ONE 5, e12733 (2010).","journal-title":"PLoS ONE"},{"key":"10004_CR43","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 18, 1639\u20131642 (2012).","journal-title":"Nat. Med."},{"key":"10004_CR44","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","volume":"67","author":"YL Lyu","year":"2007","unstructured":"Lyu, Y. L. et al. Topoisomerase II mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res. 67, 8839\u20138846 (2007).","journal-title":"Cancer Res."},{"key":"10004_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.20455\/ros.2016.835","volume":"1","author":"H Zhu","year":"2016","unstructured":"Zhu, H. et al. Doxorubicin redox biology: redox cycling, topoisomerase inhibition, and oxidative stress. React. Oxyg. Species Apex NC 1, 189\u2013198 (2016).","journal-title":"React. Oxyg. Species Apex NC"},{"key":"10004_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbabio.2011.11.011","volume":"1817","author":"B Agarwal","year":"2012","unstructured":"Agarwal, B., Camara, A. K. S., Stowe, D. F., Bosnjak, Z. J. & Dash, R. K. Enhanced charge-independent mitochondrial free Ca2+ and attenuated ADP-induced NADH oxidation by isoflurane: implications for cardioprotection. Biochim. Biophys. Acta BBA Bioenerg. 1817, 453\u2013465 (2012).","journal-title":"Biochim. Biophys. Acta BBA Bioenerg."},{"key":"10004_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/vr.c3611","volume":"167","author":"JY Lee","year":"2010","unstructured":"Lee, J. Y., Jee, H. C., Jeong, S. M., Park, C. S. & Kim, M. C. Comparison of anaesthetic and cardiorespiratory effects of xylazine or medetomidine in combination with tiletamine\/zolazepam in pigs. Vet. Rec. 167, 245\u2013249 (2010).","journal-title":"Vet. Rec."},{"key":"10004_CR48","doi-asserted-by":"publisher","first-page":"e0215579","DOI":"10.1371\/journal.pone.0215579","volume":"14","author":"J Sivapackiam","year":"2019","unstructured":"Sivapackiam, J. et al. 68Ga-Galmydar: a PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity. PLoS ONE 14, e0215579 (2019).","journal-title":"PLoS ONE"},{"key":"10004_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41598-018-36721-5","volume":"9","author":"ZM Safee","year":"2019","unstructured":"Safee, Z. M. et al. Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT. Sci. Rep. 9, 216 (2019).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10004-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:52:01Z","timestamp":1669341121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10004-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10004"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10004-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patent US 11,109,819 B2, \u2018System and method for quantitatively mapping mitochondrial membrane potential\u2019 (status: granted) is assigned to The General Hospital Corporation and lists Drs. Alpert, El Fakhri, Guehl and Normandin as inventors. The other authors declare that they have no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6122"}}